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Abstract
Background: The optimal surgical margins assessment is capital in oral squamous cell carcinoma (OSCC)
management. We evaluated the clinical benefits of integrating intraoperative macroscopic margin (MM) assessment
and narrow band imaging (NBI).
Methods: Sixteen OSCC patients eligible for surgery were prospectively enrolled. For each patient, 2 to 6 bioptic
samples of MM and NBI margins were obtained and histologically analyzed for the presence of dysplasia and
lymphocytes. Microvessel density was investigated by CD34 immunohistochemistry.
Results: Taken together, 104 specimens were analyzed, including 15% tumors, 33% MM, 33% NBI margins, and 19%
MM-NBI overlapping margins. The NBI margins were closer to the lesion in 50% cases, while the same number of
MM were more conservative than NBI, irrespective of the tumor site. The rate of histologically positive margins was
similar among the two methods, akin to the microvessel density.
Conclusions: MM assessment should be integrated but not replaced with the NBI technology to allow for more
conservative surgery.
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Background
Oral squamous cell carcinoma (OSCC) is the most fre-
quent histological type of head and neck cancer and one
of the most prevalent malignant neoplasms worldwide
[1]. Despite the recent achievements in the diagnosis
and treatment of these patients, OSCC is showing in-
creasingly high recurrence rates [2, 3]. Due to its clinical
and biological complexity, therapeutic decision-making
is not an easy task, even in multidisciplinary settings.
Anatomical site, clinical stage, and pathological features
of the primary tumor are the foremost elements to guide
OSCC treatment, which remains surgically-based either
in single or in combined therapeutic settings [4]. During
surgical removal, the visible neoplastic area should be
resected with a threshold of normal tissue, whose edge
represents the mucosal margin [5]. To improve patient’s
outcome, the surgical radicality (i.e. histologically-proved
negativity of the mucosal margin) is fundamental [6]. In-
deed, there are multiple lines of evidence to suggest that
failure to reach clear margins in OSCC is related to
an increased risk of local recurrence and, subsequently,
reduced chances of survival. However, there are no
widely adopted guidelines for pre- and intra-operative
margins identification. To date, finding the “golden strat-
egy” for the optimal assessment of the surgical mar-
gins remains one of the most critical issues in OSCC
management [7, 8].
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Several approaches have been proposed to enhance
the traditional white-light macroscopic margins (MM)
identification in OSCC. Among them, the Narrow Band
Imaging (NBI) technology have shown good perform-
ance and is currently employed in several Centers [9,
10]. This augmented reality tool increases the contrast
between the epithelial surface and the subjacent vascular
network, allowing for the visualization of the mucosal
and submucosal (micro) vascular patterns. The principle
by which NBI can be employed for surgical margin as-
sessment is based on the evidence that neoangiogenesis
is a crucial step in tumor growth and metastatic spread.
Therefore, the in vivo analysis of blood-specific light
traces could help identifying oral potentially malignant
disorders or even overt malignant conditions at the per-
iphery of the resected tumor. Furthermore, several stud-
ies have demonstrated that microvessel density (MD)
assessed by histological and immunohistochemical ana-
lysis can be employed as a prognostic biomarker for
OSCC [11–13].
Our work aims to evaluate the potential surgical bene-
fits of mucosal margin assessment for OSCC using a
platform which integrates intraoperative MM and NBI.
Methods
Patients and tissue specimens
This pilot prospective non-randomized study was approved
by the local ethics committee (approval #19_2018bis). A
total of 16 patients (10 males, 6 females) with OSCC eligible
for surgical treatment were enrolled. Informed consent was
obtained from all patients. Only patients diagnosed and
managed in IRCCS Ca′ Granda Foundation – Policlinico
Maggiore Hospital, Milan, Italy, > 18 years old, chemother-
apy- and radiotherapy-naïve, with no history of cancer were
included. All patients underwent surgical treatment with a
program established according to the guidelines of the
American Joint Committee on Cancer (7th edition) [2].
Macroscopic and narrow band imaging surgical margins
assessment in vivo
The MM was assessed by a craniofacial surgeon at a dis-
tance of 1,5–2 cm from the tumor, as described (Fig. 1a)
[7, 14]. Subsequently, two ears, nose and throat (ENT)
surgeons performed intraoperative NBI endoscopic
evaluation using a scope of 4 mm outside diameter
(Olympus Visera Pro system, Center Valley, PA America,
with OTV-S7Pro camera and CLV-S40Pro light source).
This intraoperative analysis allowed for the identification
of the interface between the likely neoplastic/dysplastic
and likely healthy areas, i.e. NBI margin. Next, the max-
illofacial surgeon performed multiple biopsies of both
the MM and the NBI margins. For each patient, from 2
to 6 bioptic samples were obtained. The NBI margins
were then classified as overlapping, external, or internal,
compared to the MM. In case of overlap between the
MM and NBI margins, only one biopsy was performed
(Fig. 1).
Histopathological analysis and pathologic surgical
margins assessment
Hematoxylin and eosin (H&E) stained frozen sections of
the MM margins were intraoperatively analyzed by a
pathologist as part of the standard protocol to drive the
surgical intervention. All surgical samples, including the
tumor, the MM and NBI margins, were then analyzed
after tissue processing by two pathologists (NF and MM),
as shown in Fig. 1a. Specifically, all cases were classified
and graded following the latest World Health
Organization criteria [15]. Pathologic staging was assessed
according to the current TNM staging system [16]. The
presence of tumor infiltrating lymphocytes (TILs) was
assessed as described [17]. The MM and NBI surgical
margins were defined as positive in the presence of OSCC
and/or dysplasia; otherwise, they were marked as negative.
Immunohistochemistry and microvessel density analysis
MD was investigated by immunohistochemistry (IHC)
in the MM and NBI surgical margins. Representative
4-μm-thick sections were cut from the MM, NBI, and
tumor blocks and subjected to IHC using pre-diluted
antibodies against CD34 as previously described [18].
Positive and negative controls were included in each
slide run. Briefly, the protocols use an automated
staining system (Dako Omnis) and anti-human predi-
luted antibodies [19]. Protein expression was analyzed
in all different samples by two independent patholo-
gists (NF and SF). Discordant results were resolved
during dedicated consensus sessions. Sections were
first observed at low magnification (40x) to identify
the areas with the higher concentration of vessels.
Then, the vessels count was performed at 200x by
means of a customized digital image analysis algo-
rithm using the Aperio CS2 instrument (Leica Micro-
systems Srl) [20]. The MD value was expressed as a
percentage. Each CD34-positive structure (round, oval,
and irregular) separated from other profiles or tissue
elements was counted as a single vessel, regardless of
the presence of a clear lumen.
Statistical analysis
Data were analyzed using Prism 4.0 (GraphPad Inc.,
La Jolla, CA, USA). Differences among sample groups
were analyzed using the unpaired Student’s t-test as
previously described [21]. The association between
positive margins was evaluated by Fisher’s exact test
according to the classification proposed by Piazza and
collaborators [22]. Statistical significance was assumed
for a probability value (p) less than 0.05.
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Results
Sixteen patients (10 males and 6 females) who under-
went surgery for OSCC were included in this study
(age 23 to 92 years old, mean 68 years). Tumor sites
included the tongue (n = 6), lower alveolar ridge/man-
dible (n = 3), hard palate (n = 2), cheek (n = 2), floor
of mouth (n = 2), and upper alveolar ridge/maxilla
(n = 1). Clinicopathologic data are summarized in
Table 1.
Integration of MM and NBI margins is superior to MM
and NBI alone
Taken together, 104 specimens were analyzed, including
16 (15.4%) tumors, 34 (32.7%) MM, 34 (32.7%) NBI
margins, and 20 (19.2%) MM-NBI overlapping margins
(Fig. 1b). The NBI margins were closer to the lesion in
17 (50%) cases (Fig. 1b) compared to the MM assess-
ment. However, this method showed no propensity to
allow for a more conservative resection, given that in
the same number of margins (n = 17, 50%) was the MM
the more conservative approach. Furthermore, this het-
erogeneity was irrespective of the tumor site and was
not present at a single-patient level. At the histological
examination, the margins collected with the MM intra-
operative assessment revealed dysplasia in 3 (8.8%)
cases and OSCC in 1 (2.9%) case, while 30 (88.2%) sam-
ples were negative as represented in Table 2 and Fig. 2a.
The analysis of the NBI margins showed dysplasia and
Fig. 1 a Schematic overview of the study. TILs are highlighted by stars. Original magnification of the micrographs 100X. b Schematic image of MM and
NBI margins for the 16 OSCC patients. Red dots represent the cardinal points related to the biopsies performed for the excision of the mucosal margins
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OSCC in 2 (5.9%) and 1 (2.9%) cases; respectively, while
31 (91.2%) margins were negative, as confirmed by
histological examination (Table 2 and Fig. 2b). Among
the 20 overlapping MM-NBI margins, 2 (10%) cases
were positive. In particular, positive margins showed a
significant association with thick and thin non-
keratinized epithelial cells [23] (p = 0.027). These data
suggest that the intraoperative integration of MM and
NBI analysis might allow for a more conservative exci-
sion of OSCC compared to each of the two methods
alone.
High levels of microvessel density are related to positive
mucosal margins irrespective of the method used for
their assessment
MD has been investigated in 83 margins and matched
OSCCs. This analysis showed significantly high CD34
levels in pathological margins compared to the normal
ones (p < 0.0001, Fig. 2c). This observation was unre-
lated to the intraoperative method of surgical margins
assessment (i.e. MM and NBI). Internal and external
margins didn’t show a statistically significant different
MD, akin to the tumor site.
Discussion
The use of new technologies to investigate tumor behav-
ior and microenvironment is of great interest in this era
of precision medicine. Several studies unraveled the role
of molecular biomarkers for the diagnostic and thera-
peutic process in patients with OSCC [24–26]. The
application of “biologic endoscopy” to intraoperative sur-
gical procedures represents another step forward to-
wards the realization of the potentials of customized
surgery [9, 10, 27, 28]. Autofluorescence detection and
NBI technology have already been tested in the defin-
ition of resection margins in OSCC and demonstrated to
be reliable and cost-effective [9, 29]. Poh et al. [29] de-
scribed the ability of autofluorescence to identify malig-
nant and pre-malignant lesions. Tirelli et al. [10]
reported an overall diagnostic gain of 8.5% using NBI,
allowing a better definition of the tumor extension. They
observed adequate resection margins in 74.2% of cases.
Moreover, a resection enlargement of 11 ± 3mm was
performed consequently for intraoperative NBI evalu-
ation [9], which revealed moderate dysplasia and cancer
in 25 and 75% of samples respectively.
In this study, we performed a comparison between the
mucosal margins assessment by MM and NBI, using
their histological counterparts as "gold standard". Over-
all, we have observed that 50% of NBI margins were
external or internal to the traditional surgical (i.e.
MM) ones. These results confirm previous observations
that NBI margins are usually wider than MM margins
[9]. Interestingly, we observed that in approximately 30%
of cases the NBI technology coupled with traditional
surgical assessment is able to reduce the extent of the
resection, as confirmed by the histological analysis.
Table 1 Demographic and clinicopathologic features of the
study group
Features Number of cases (%)
Sex
Male 10 (62.5)
Female 6 (37.5)
Age
Mean 68.25
Smoking
Yes 3 (19)
No 4 (25)
Ex smoker 9 (56)
Alcohol
Yes 12 (75)
No 3 (19)
Ex drinker 1 (6)
Site
Tongue 6 (37.5)
Mandible 3 (19)
Palate 2 (12.5)
Cheek 2 (12.5)
Floor of the mouth 2 (12.5)
Maxilla 1 (6)
T Staging
T1 6 (37.5)
T2 5 (31.25)
T3 1 (6.25)
T4 4 (25)
N Staging
Nx 3 (18.75)
N0 7 (43.75)
N1 3 (18.75)
N2 3 (18.75)
Grading
G1 2 (12.5)
G2 13 (76.4)
G3 1 (6.25)
Vascular invasion
Yes 0
No 9 (56.25)
Perineural invasion
Yes 5 (31.25)
No 11 (68.75)
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Moreover, NBI and MM specimens revealed 2 and 3
mild dysplasia, respectively. In particular, positive mar-
gins were significantly localized in thick and thin
non-keratinized epithelia with a low papillary density
[23]. These data confirm the safety of the NBI technique
and provide previously unavailable data that the integra-
tion of MM and NBI margins is superior to MM and
NBI alone in OSCC surgical management [23, 30].
There are several lines of evidence that the activation of
neoangiogenesis pathways represents a founder molecular
event in OSCC initiation and progression [31]. Previous
studies have demonstrated that high levels of MD are as-
sociated with a more aggressive clinical course in head
and neck cancers [31–35]. In the present study, MD was
quantified by the measurement of the areas lined by ele-
ments expressing CD34, which is a transmembrane pro-
tein encoded by the homonymous gene located at
chromosome 1q. Taken together, we detected significant
higher levels of MD in the positive margins compared to
the normal mucosa. In several solid tumors, neoangiogen-
esis carries heavy traffic of non-malignant cells, especially
B and T lymphocytes. These data confirm crucial role of
the immune surveillance in head and neck cancer [36, 37].
Here, we evaluated the surgical margins status in
OSCC by means of NBI endoscopy and the pathological
identification of neoangiogenesis and intratumor im-
mune response. This pilot study highlights that the sur-
gical and NBI margins are comparable in terms of
reliability. This notion, however, should be considered in
the context of the small sample size investigated in the
present work. An intrinsic limitation of this study is rep-
resented by absence of deep margin assessment, given
that the NBI technology allows only for the evaluation of
the perimetral margins. Further prospective studies
Table 2 Demographic, clinicopathologic characteristics, and surgical margins status of the patients included in this study. NBI,
narrow-band imaging; MM, macroscopic margin, AU, alcohol units; n.a., not available; RT, radiotherapy; CT, chemotherapy. When NBI
and MM were overlapping, only one biopsy was performed
Case Age
(range)
Smoking Alcohol Site Piazza et al.
Classification [23]
Staging
TNM
Grading Lympho-
vascular/
Perineural
invasion
Sample
1 NBI/
MM
Sample
2 NBI/
MM
Sample
3 NBI/
MM
Sample
4 NBI/
MM
Adjuvant
Therapy
1 50–60 No Yes (2
AU/die)
Lateral Tongue 2b T1Nx G2 No/No – −/− – – No
2 70–80 Ex Yes (2
AU/die)
Floor of mouth 2a T2 N0 G2 No/Yes −/− – n.a. n.a. RT
3 50–60 Yes Yes (2
AU/die)
Ventral Tongue 2a T2 N0 G2 No/Yes −/− −/− n.a. n.a. RT
4 50–60 Ex Yes (1
AU/die)
Floor of mouth 2a T1(m)Nx n.a. No/No +/− −/− −/− n.a. CT + RT
5 50–60 Ex Yes (1
AU/die)
Maxilla/Alveolar
Mucosa
1 T4aNx G1 No/No −/− −/− n.a. n.a. No
6 > 80 No Yes (1
AU/die)
Mandible/
Alveolar Mucosa
1 T4aN0 G1 No/No −/− −/− −/− −/− No
7 60–70 Ex Yes (1
AU/die)
Lateral Tongue 2b T1 N1(E-
)R1
G2 No/No n.a. −/− – −/+ CT + RT
8 > 80 No No Cheek 2b T2N1R0 G2 No/Yes n.a. −/+ −/− – No
9 > 80 No Ex
Drinker
Hard Palate 1 T4aN2b
(E-) R0
G2 No/No – – – −/− No
10 70–80 Ex No Mandible/
Retromolar
Trigone
2b T2 N1
(E-) R0
G3 No/No +/− – −/− −/− RT
11 < 30 Ex Yes (1
AU/die)
Lateral Tongue 2b T2N2b G2 No/Yes +/+ −/− + −/− CT + RT
12 60–70 Ex Yes (1
AU/die)
Mandible/
Alveolar Mucosa
1 T2 N0R0 G2 No/Yes – −/− – – No
13 > 80 Yes No Lateral Tongue 2b T1N2b G2 No/No – – – −/+ No
14 > 80 Ex Yes (1
AU/die)
Cheek 2b T1 N0 G2 No/No + −/− −/− −/− No
15 70–80 Ex Yes (1
AU/die)
Hard Palate 1 T4aN0 G2 No/No – −/− −/− −/− No
16 50–60 Yes Yes (1
AU/die)
Floor of mouth 2a T1 N0 G2 No/No – −/− n.a. −/− No
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embracing larger cohorts of patients are warranted to
define the operational implications of our observations.
This would lead to standardized intraoperative employ-
ment of this novel integrated strategy.
Conclusion
The integration of the traditional MM assessment with
the NBI technology can allow for more conservative sur-
gical interventions in OSCC.
Abbreviations
ENE: Extranodal extension; ENT: Ears, nose and throat; H&E: Hematoxylin and
eosin; IHC: Immunohistochemistry; MD: Microvessel density;
MM: Macroscopic margins; NBI: Narrow band imaging; OSCC: Oral squamous
cell carcinoma; TILs: Tumor infiltrating lymphocytes
Acknowledgments
The Authors would like to thank Prof. Alto Gianni’, Prof. Stefano Ferrero, and
Prof. Lorenzo Pignataro for fostering this study.
Funding
Not applicable.
Availability of data and materials
The dataset used and analysed during the present study is available from
the corresponding author upon reasonable request.
Authors’ contributions
Study concept, design, and supervision by ABa and NF. Acquisition, analysis,
and interpretation of data: AB, NF, ABa, DC, and CM. ABo, DC, CM and LB
reviewed the clinical records. Clinicopathologic correlations were performed
by ABa, NF, and PC, with the substantial contribution of ABo and AF. Initial
histologic review of the cases was performed by NF and MM. The statistical
analysis was carried out by NF and AF. Iconography and image processing
by CM, AF, and NF. CM wrote the first draft of the manuscript, which was
initially reviewed by Aba, AF, and NF. Subsequently, all authors edited and
approved the final draft.
Ethics approval and consent to participate
The study was approved by the ethics committee of the Fondazione IRCCS
Ca′ Granda under the vote #19_2018bis. All participants signed informed
consent forms.
Fig. 2 a Representative histological micrographs of the primary tumor, NBI and MM margins in a case (#7) where NBI margins are negative and a
MM shows low-grade dysplasia. b Representative histological micrographs of the primary tumor, NBI and MM margins in a case (#4) were an NBI
margin is positive for high-grade dysplasia, while MM are negative. Original magnification is 100X. c CD34 protein levels in positive (red) and
negative (cyan) margins. p < 0.0001 by unpaired Student’s t-test
Baj et al. BMC Cancer          (2019) 19:467 Page 6 of 7
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1Department of Biomedical, Surgical, and Dental Sciences, University of
Milan, Fondazione IRCCS Ca’ Granda Policlinico, via Francesco Sforza, 35,
20122 Milan, Italy. 2Maxillo-Facial Surgery and Odontostomatology Unit,
Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy.
3Division of Pathology, Fondazione IRCCS Ca’ Granda Ospedale Maggiore
Policlinico, Milan, Italy. 4Otolaryngology Unit, Fondazione IRCCS Ca’ Granda
Ospedale Maggiore Policlinico, Milan, Italy.
Received: 4 January 2019 Accepted: 23 April 2019
References
1. Marur S, Forastiere AA. Head and neck squamous cell carcinoma: update on
epidemiology, diagnosis, and treatment. Mayo Clin Proc. 2016;91(3):386–96.
2. Edge SB, Compton CC. The American joint committee on Cancer: the 7th
edition of the AJCC cancer staging manual and the future of TNM. Ann
Surg Oncol. 2010;17(6):1471–4.
3. Garavello W, Bertuccio P, Levi F, et al. The oral cancer epidemic in central
and eastern Europe. Int J Cancer. 2010;127(1):160–71.
4. Adelstein D, Gillison ML, Pfister DG, et al. NCCN guidelines insights: head
and neck cancers, version 2. J Natl Compr Canc Netw. 2017;15(6):761–70.
5. Shah AK. Postoperative pathologic assessment of surgical margins in oral
cancer: a contemporary review. J Oral Maxillofac Pathol. 2018;22(1):78–85.
6. Loree TR, Strong EW. Significance of positive margins in oral cavity
squamous carcinoma. Am J Surg. 1990;160(4):410–4.
7. Hinni ML, Ferlito A, Brandwein-Gensler MS, et al. Surgical margins in head
and neck cancer: a contemporary review. Head Neck. 2013;35(9):1362–70.
8. Tirelli G, Zacchigna S, Boscolo Nata F, Quatela E, Di Lenarda R, Piovesana M.
Will the mininvasive approach challenge the old paradigms in oral cancer
surgery? Eur Arch Otorhinolaryngol. 2017;274(3):1279–89.
9. Tirelli G, Piovesana M, Gatto A, Tofanelli M, Biasotto M, Boscolo Nata F.
Narrow band imaging in the intra-operative definition of resection margins
in oral cavity and oropharyngeal cancer. Oral Oncol. 2015;51(10):908–13.
10. Tirelli G, Piovesana M, Gatto A, Torelli L, Di Lenarda R, Boscolo Nata F. NBI
utility in the pre-operative and intra-operative assessment of oral cavity and
oropharyngeal carcinoma. Am J Otolaryngol. 2017;38(1):65–71.
11. Jalayer Naderi N, Tirgari F, Keshavarz Z. Vascular endothelial growth factor
expression and vascular density in oral squamous cell carcinoma (OSCC): a
study on clinical and histopathologic significance. Med J Islam Repub Iran.
2016 Apr 18;30:358.
12. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and
metastasis--correlation in invasive breast carcinoma. N Engl J Med. 1991;
324(1):1–8.
13. Ingaleshwar PS, Pandit S, Desai D, Redder CP, Shetty AS, Mithun KM.
Immunohistochemical analysis of angiogenesis by CD34 and mast cells by
toluidine blue in different grades of oral squamous cell carcinoma. J Oral
Maxillofac Pathol. 2016;20(3):467–73.
14. Williams MD. Determining adequate margins in head and neck cancers:
practice and continued challenges. Curr Oncol Rep. 2016;18(9):54.
15. General Assembly of the World Medical Association. World medical
association declaration of Helsinki: ethical principles for medical research
involving human subjects. J Am Coll Dent. 2014 Summer;81(3):14–8.
16. Amin MB, Edge SB, Greene FL, et al. AJCC Cancer staging manual. Eighth
ed. New York, NY: Springer; 2017.
17. Klauschen F, Müller KR, Binder A, et al. International scoring of tumor-
infiltrating lymphocytes: from visual estimation to machine learning. Semin
Cancer Biol. 2018;52(Pt 2):151-157.
18. Ercoli G, Lopez G, Ciapponi C, et al. Building Up a High-throughput
Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification
in Breast Cancers. J Vis Exp. 2017;5(130).
19. Sciarra A, Lopez G, Corti C, et al. Columnar cell lesion and apocrine
hyperplasia of the breast: is there a common origin? The role of prolactin-
induced protein. Appl Immunohistochem Mol Morphol. 2017 Oct 27.
20. Fusco N, Guerini-Rocco E, Del Gobbo A, et al. The contrasting role of
p16Ink4A patterns of expression in neuroendocrine and non-
neuroendocrine lung tumors: a comprehensive analysis with
Clinicopathologic and molecular correlations. PLoS One. 2015;10(12):
e0144923.
21. Fusco N, Lopez G, Corti C, et al. Mismatch repair protein loss as a
prognostic and predictive biomarker regardless of microsatellite instability.
JNCI Cancer Spectrum. 2018 Nov;4(2):pky056.
22. Szafarowski T, Sierdzinski J, Szczepanski MJ, Whiteside TL, Ludwig N, Krzeski
A. Microvessel density in head and neck squamous cell carcinoma. Eur Arch
Otorhinolaryngol. 2018;275(7):1845–51.
23. Piazza C, Del Bon F, Paderno A, et al. The diagnostic value of narrow band
imaging in different oral and oropharyngeal subsites. Eur Arch
Otorhinolaryngol. 2016;273(10):3347–53.
24. Irimie AI, Braicu C, Cojocneanu-Petric R, Berindan-Neagoe I, Campian RS.
Novel technologies for oral squamous carcinoma biomarkers in diagnostics
and prognostics. Acta Odontol Scand. 2015;73(3):161–8.
25. Retzbach EP, Sheehan SA, Nevel EM, et al. Podoplanin emerges as a
functionally relevant oral cancer biomarker and therapeutic target. Oral
Oncol. 2018;78:126–36.
26. Song W, Sun Y, Lin J, Bi X. Current research on head and neck cancer-
associated long noncoding RNAs. Oncotarget. 2017;9(1):1403–25.
27. Sinha P, Bahadur S, Thakar A, et al. Significance of promoter
hypermethylation of p16 gene for margin assessment in carcinoma tongue.
Head Neck. 2009;31(11):1423–30.
28. Tirelli G, Piovesana M, Marcuzzo AV, et al. Tailored resections in oral
and oropharyngeal cancer using narrow band imaging. Am J
Otolaryngol. 2018;39(2):197–203.
29. Poh CF, Zhang L, Anderson DW, et al. Fluorescence visualization detection
of field alterations in tumor margins of oral cancer patients. Clin Cancer Res.
2006;12(22):6716–22.
30. Tirelli G, Piovesana M, Gatto A, Torelli L, Boscolo Nata F. Is NBI-guided
resection a breakthrough for achieving adequate resection margins in Oral
and oropharyngeal squamous cell carcinoma? Ann Otol Rhinol Laryngol.
2016;125(7):596–601.
31. Naderi NJ, Tirgari F, Keshavarz Z. Vascular endothelial growth factor
expression and vascular density in oral squamous cell carcinoma (OSCC): a
study on clinical and histopathologic significance. Med J Islam Repub Iran.
2016;30(1):1–6.
32. Albo D, Granick M, Jhala N, Atkinson B, Solomon MP. The relationship of
angiogenesis to biological activity in human squamous cell carcinomas of
the head and neck. Ann Plast Surg. 1994;32(6):588–94.
33. Ascani G, Balercia P, Messi M. Lupi et al. Angiogenesis in oral squamous cell
carcinoma. Acta Otorhinolaryngol Ital. 2005;25(1):13–7.
34. Shivamallappa SM, Venkatraman NT, Shreedhar B, Mohanty L, Shenoy S.
Role of angiogenesis in oral squamous cell carcinoma development and
metastasis: an immunohistochemical study. Int J Oral Sci. 2011;3(4):216–24.
35. Li SH, Hung PH, Chou KC, Hsieh SHSY. Tumor angiogenesis in oral
squamous cell carcinomas: the significance of endothelial markers and
hotspot selection. J Med Sci. 2009;29:67–74.
36. Lei Y, Xie Y, Tan YS, et al. Telltale tumor infiltrating lymphocytes (TIL) in oral,
head & neck cancer. Oral Oncol. 2016;61:159–65.
37. Wolf GT, Chepeha DB, Bellile E, Nguyen A, Thomas D, McHugh J. University
of Michigan head and neck SPORE program. Tumor infiltrating lymphocytes
(TIL) and prognosis in oral cavity squamous carcinoma: a preliminary study.
Oral Oncol. 2015;51(1):90–5.
Baj et al. BMC Cancer          (2019) 19:467 Page 7 of 7
